NCT00157937View on ClinicalTrials.gov

A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
AsthmaAllergic Rhinitis
Interventions
DRUG

MK0476; montelukast sodium/Duration of Treatment: 16 weeks

DRUG

Comparator: theophylline ER/Duration of Treatment: 16 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00157937 - A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329) | Biotech Hunter | Biotech Hunter